2012, ISBN: 9782817803364
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and … mais…
Orellfuessli.ch Nr. 34928972. Custos de envio:, Sofort per Download lieferbar, zzgl. Versandkosten, Lieferzeiten außerhalb der Schweiz 3 bis 21 Werktage. (EUR 16.66) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), Auflage, [PU: Springer-Verlag], [ED: 1], Springer-Verlag, 2012
lehmanns.de Custos de envio:Download sofort lieferbar. (EUR 29.95) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, [ED: 1], Auflage, eBook Download (PDF), eBooks, [PU: Springer-Verlag]
lehmanns.de Custos de envio:Download sofort lieferbar, , Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), 2012, [PU: Springer Paris], Springer Paris, 2012
lehmanns.de Custos de envio:Download sofort lieferbar. (EUR 0.00) Details... |
2012, ISBN: 9782817803364
A New Generation of Biologics, 2012, eBook Download (PDF), eBooks, [PU: Springer Paris]
lehmanns.de Custos de envio:Download sofort lieferbar, , Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
no/na Orellfuessli.ch
2012, ISBN: 9782817803364
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and … mais…
Jean-Louis Prugnaud; Jean-Louis Prugnaud; Jean-Hugues Trouvin; Jean Hugues Trouvin:
Biosimilars - primeira edição2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), Auflage, [PU: Springer-Verlag], [ED: 1], Springer-Verlag, 2012
2012
ISBN: 9782817803364
A New Generation of Biologics, [ED: 1], Auflage, eBook Download (PDF), eBooks, [PU: Springer-Verlag]
2012, ISBN: 9782817803364
A New Generation of Biologics, eBooks, eBook Download (PDF), 2012, [PU: Springer Paris], Springer Paris, 2012
2012, ISBN: 9782817803364
A New Generation of Biologics, 2012, eBook Download (PDF), eBooks, [PU: Springer Paris]
Dados bibliográficos do melhor livro correspondente
Autor: | |
Título: | |
Número ISBN: |
Dados detalhados do livro - Biosimilars
EAN (ISBN-13): 9782817803364
ISBN (ISBN-10): 2817803361
Ano de publicação: 2012
Editor/Editora: Springer-Verlag
87 Páginas
Língua: eng/Englisch
Livro na base de dados desde 2012-09-27T12:56:33-03:00 (Sao Paulo)
Página de detalhes modificada pela última vez em 2023-02-28T22:27:40-03:00 (Sao Paulo)
Número ISBN/EAN: 2817803361
Número ISBN - Ortografia alternativa:
2-8178-0336-1, 978-2-8178-0336-4
Ortografia alternativa e termos de pesquisa relacionados:
Autor do livro: hugues, jean louis lou
Dados da editora
Autor: Jean-Louis Prugnaud; Jean-Hugues Trouvin
Título: Biosimilars - A New Generation of Biologics
Editora: Springer; Springer Paris
90 Páginas
Ano de publicação: 2012-11-27
Paris; FR
Impresso / Feito em
Língua: Inglês
117,69 € (DE)
142,00 CHF (CH)
Available
XVIII, 90 p.
EA; E107; eBook; Nonbooks, PBS / Medizin/Klinische Fächer; Onkologie; Verstehen; Biomedicine; Biosimilars; Cost; Immunogenicity; Interchangeability; C; Oncology; Nephrology; Pharmacy; Pharmaceutical Sciences/Technology; Immunology; Oncology; Nephrology; Pharmacy; Pharmaceutics; Immunology; Medicine; Nierenheilkunde, Nephrologie; Pharmazie, Apotheke; Medizinische Chemie, Pharmazeutische Chemie; Immunologie; BB
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context.Outros livros adicionais, que poderiam ser muito similares com este livro:
Último livro semelhante:
9782817805146 Biosimilars (Jean-Louis Prugnaud; Jean-Hugues Trouvin)
< Para arquivar...